Renagel (Genzyme Corporation)
Welcome to the PulseAid listing for the Renagel drug offered from Genzyme Corporation. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genzyme Corporation |
NON-PROPRIETARY NAME: | Renagel |
SUBSTANCE NAME: | SEVELAMER HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-06-06 |
END MARKETING DATE: | 0000-00-00 |
Renagel HUMAN PRESCRIPTION DRUG Details:
Item Description | Renagel from Genzyme Corporation |
LABELER NAME: | Genzyme Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2008-06-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58468-0020_4181ad6d-70e4-4682-bda7-4921da949aa8 |
PRODUCT NDC: | 58468-0020 |
APPLICATION NUMBER: | NDA021179 |
Other SEVELAMER HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: